-+ 0.00%
-+ 0.00%
-+ 0.00%

INTELLIA THERAPEUTICS SHARES UP 23.7% PREMARKET AFTER US FDA LIFTS CLINICAL HOLD ON ONE OF CO'S GENE THERAPY TRIALS

Reuters·01/27/2026 13:54:44

Please log in to view news